Log In
Print
BCIQ
Print
Print this Print this
 

AMP-110

  Manage Alerts
Collapse Summary General Information
Company AstraZeneca plc
DescriptionFusion protein containing the extracellular domain of B7-H4 (V-set domain containing T cell activation inhibitor; VTCN1) and the Fc-portion of IgG
Molecular Target V-set domain containing T cell activation inhibitor 1 (B7-H4) (VTCN1)
Mechanism of Action 
Therapeutic ModalityBiologic: Fusion protein

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today